Keeping the conditions. Carry the evidence forward.

The proposed collection begins with a development question.

A formulation or ingredient team may need to compare several reported results without losing the preparation, conditions or endpoint behind each number. The proposed Evidence Collections would organise that record for a defined question: which evidence can be compared, what changes between the studies and what the next experiment would need to resolve.

The buyer would receive a structured analysis package rather than an indiscriminate feed of papers. The proposed first use is a technical team evaluating a bounded material function or comparative method. A broad automated recommendation of ingredients would require a different evidence base and is not the intended starting product.

For example, a team preparing a polymer comparison may find water-related observations reported under different conditions or on different preparations. The collection would retain those differences so that the evaluator can decide whether the numbers address the same question. The proposed value is an inspectable path from the source to the next study requirement, rather than a larger table that implies comparability because the values share a unit.

Depth can create more value than an unmanageable source count.

A possible first collection is evidence relevant to a deposited-film material comparison. Each observation would retain the preparation, method, comparator, loading, units, endpoint, source location and relevant uncertainty. The analysis could separate directly comparable records from those that only suggest a hypothesis, avoiding a misleading combined ranking.

The proposed output would include a machine-readable record, a human-readable decision note and a change log. A developer could inspect the source basis; an application scientist could review the reasoning; a project sponsor could see which missing information affects the next commitment. That is the product hypothesis to validate.

The customer would identify the application, the decision being supported, the preparations of interest and the format its team can use. A reviewer would define the inclusion criteria and record why relevant sources were excluded or treated separately. Where units can legitimately be converted, the original value and transformation should remain visible. Where conditions prevent a valid comparison, the collection should preserve separate records rather than manufacture a combined estimate.

A readable paper is not blanket permission to redistribute it.

PMC states that article licences vary and identifies the services permitted for automated retrieval. Springer Nature’s API terms also distinguish access permissions from reuse conditions. A commercial collection therefore needs a record-level rights basis and an appropriate retrieval route, rather than assuming that everything accessible online can enter a paid product (National Library of Medicine, 2026; Springer Nature, n.d.).

A proposed refresh would identify the sources checked, the review date, changed records and the consequence for the analysis. Weekly or monthly publication would be useful only where relevant new evidence warrants it. A dated collection with honest coverage can be more valuable than a nominally live feed that repeats unchanged information.

Existing search engines, publication alerts and supplier databases may already meet a team’s need for discovery. A paid collection should therefore justify the additional work through a specific review, consistent observation context or a maintained decision record. The buyer should be able to identify what has changed and why it matters. If a scheduled check finds no relevant change, the release should say so rather than imply fresh findings.

(National Library of Medicine, 2026) | (Springer Nature, n.d.)